Columbia, MD – April 2, 2026 – Advarra, the industry leader in integrated solutions for research sites and institutions, today announced it will unveil site technology enhancements at Onsemble 2026 (April 13–16, Orlando, FL), the largest conference for the OnCore and Clinical Conductor CTMS user community. Spanning new product feedback mechanisms, automation, integrations, and advanced analytics, the enhancements aim to further reduce site burden and streamline connectivity across the clinical research ecosystem.
Now in its 20th year, Onsemble is the industry’s premier technology conference for clinical research sites to share best practices and help shape the future of site technology. This year’s event marks the debut of Advarra Voice, a new, interactive voting solution that gives customers a direct role in prioritizing future product innovations. Onsemble attendees will be the first to experience Advarra Voice in action.
“Advarra Voice gives our customers a direct, transparent hand in shaping the technology they use every day,” said Scott Uebele, chief operating officer at Advarra. “With Advarra systems as the lifeblood of research operations across sites and institutions, we are committed to focusing on what matters most to our customers and making improvements that streamline workflows, increase efficiency, and maximize study performance for the entire research community.”
At Onsemble, Advarra will also showcase new and upcoming product innovations across its site technology portfolio, a suite of integrated solutions for research sites, including OnCore, Clinical Conductor, eReg, and eSource+EDC:
- eSource+EDC integration with EHRs: The first capability via Advarra’s recent partnership with IgniteData; connects site electronic health record (EHR) systems directly to Advarra’s eSource and electronic data capture (EDC) solutions through the IgniteData Archer platform—enabling secure, automated data transfer that reduces duplicate entry and improves data quality.
- eReg automation migration tool: New capability streamlines the migration of documents from standalone regulatory systems into Advarra’s eReg, a secure, 21 CFR Part 11 compliant electronic document management system that seamlessly integrates with OnCore and Clinical Conductor CTMSs, including documents.
- Explore why research sites are increasingly switching to Advarra’s eReg technology.
- eSource+EDC patient forms: Enables direct-to-patient surveys within Advarra’s eSource+EDC for remote data collection while maintaining 21 CFR Part 11 compliance, centralizing study data and reducing reliance on external tools.
- OnCore Analytics: Expands analytics and reporting capabilities for OnCore—including improved workbook workflows, centralized report management, and budget CPT coding and Data Table 4 reporting—to reduce reconciliation, minimize billing errors, and strengthen budget forecasting.
- Clinical Conductor Analytics: New reporting capabilities deliver robust dashboards and visualizations that surface operational trends and performance insights to support data-driven decision-making.
Together, these innovations strengthen Advarra’s integrated technology for sites and institutions and, combined with its Consulting & Professional Services, reduce site burden, improve collaboration, and drive more efficient research with greater confidence.
Visit the Advarra site to learn more about Advarra’s Site Solutions.
Media Contact:
Alyson Levitz-Jones
alyson.jones@advarra.com / mediarelations@advarra.com
About Advarra
Advarra provides the platform, insights, and expertise that make clinical trials more efficient and connected. As the leading independent IRB, we bring more than 40 years of trusted oversight to the industry, setting the standard for ethical reviews while building the largest collection of digitized protocols and operational data. This combined intelligence guides the protocol’s entire journey—from design through review, activation, and conduct—fueling a smarter, more adaptive research ecosystem.
Backed by decades of partnership with research sites, Advarra delivers the core systems and services that 50,000 investigators and their study teams depend on for optimal trial operations. Integrated with our solutions for study design, startup, and conduct, these capabilities create a collaborative technology platform trusted by sponsors and CROs globally.
By designing AI-powered workflows that streamline operations, reduce administrative burden, and promote transparency for all study stakeholders, we’re reimagining what’s possible in clinical research. Learn more at www.advarra.com.